THERMAL GENERATION SYSTEM FOR A NOVEL TTS
THERMAL GENERATION SYSTEM FOR A NOVEL TTS
批准号:
3498637
负责人:
EDWARD SCHMITT
金额:
$5.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-07-01 至 1992-01-31
中文摘要
描述:(改编自申请人的摘要)
开发了一种新型脉冲透皮治疗系统(TTS),
在这个提案中描述。 TTS将使用Intelimer TM聚合物
Landec实验室专有的膜,以及热信号发生器,
驾驶他们。 由于膜对水的渗透性非常低,
各种药物低于一个“开关温度”和一个非常高的渗透性
在该温度以上,药物的释放可以被激活和控制,
通过小的热刺激来改变膜的状态。 系统
具有许多给药方案的潜力。 这样的好处
系统包括降低耐受性,改善患者依从性,
患者控制治疗。
这项提案的重点是开发一个系统,
激活Intelimer TM膜所需的刺激。 这项研究将
包括审查适用于这一概念的加热技术。 一
将使用最合适的加热方法建造原型
使用Intelimer TM聚合物。 该原型将进行评估,
响应时间、温度控制和其他参数。
最后,将热加热原型层压成透皮
一种带有药物储存器的装置。 药物的释放曲线,
将在体外监测对热刺激的反应。
英文摘要
DESCRIPTION: (Adapted from the Applicant's Abstract) The mechanical
development of a novel pulsed transdermal therapeutic system (TTS) is
described in this proposal. The TTS will utilize Intelimer TM polymeric
membranes, proprietary to Landec Labs., and a thermal signal generator to
drive them. Because the membranes have a very low permeability to a
variety of drugs below a "switch temperature" and a very high permeability
above that temperature, the release of a drug can activated and controlled
by a small heat stimulus to change the state of the membrane. The system
has potential for many dosing regimens. Benefits derived from such a
system include the reduction of tolerance, improved patient compliance, and
patient controlled therapy.
This proposal focused on the development of a system to provide the heat
stimulus required to activate the Intelimer TM membrane. The research will
encompass a review of heating technologies appropriate to this concept. A
prototype using the most appropriate heating method will be constructed
using the Intelimer TM polymers. This prototype will be evaluated with
respect to response time, temperature control, and other parameters.
Finally, the thermal heating prototype will be laminated into a transdermal
device complete with a drug reservoir. The release profile of a drug as it
responds to the heat stimulus will be monitored in vitro.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文